As the COVID-19 pandemic continues to evolve, Norgine is fully committed to doing everything we can to manage this unprecedented situation and to support our staff, customers, patients and partners through this challenging period.
Our priority is to protect the health of our staff whilst ensuring that we can continue to supply medicines and products to our customers and ultimately to the 22 million patients we help every year.
We are proud to be able to help 22 million patients worldwide every year.
Founded in 1906, Norgine is a leading European specialist pharmaceutical company with a strong global network of partnerships.
This enables us to acquire, develop and commercialise innovative products that make a real difference to the lives of patients around the world.